Find out how our scientists are developing a way to target a troublesome cancer molecule, LOX.
Our rapid turn-around funding scheme aims to fund high-risk research that we wouldn’t normally fund.
At AACR 2017, thousands of doctors and scientists shared progress in cancer research. Read about the hottest topics.
In this post we’ll be exploring the gene editing technology CRISPR by answering some of the most common questions that pop up.
For World Health Day a cancer survivor shares his story about tackling mental health issues after treatment, and how it inspired a career change.
Despite today’s headlines, there’s no good evidence linking air pollution with breast cancer.
How do you study cell division, without cells?
As the UK Government has triggered Article 50, our chief clinician looks at what the Brexit negotiations could mean for cancer.